Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS
File(s)s41366-019-0318-z.pdf (770.64 KB)
Published version
Author(s)
Type
Journal Article
Abstract
BACKGROUND: Adiposity rebound (AR), the second BMI rise in childhood at around the age of 6 years, is associated with obesity and metabolic alteration in later life. Given that polycystic ovary syndrome (PCOS) has a strong metabolic component, early life growth patterns could reveal a risk of PCOS. Thus, we aimed to investigate the associations between age at AR and PCOS diagnosis and BMI later in life. MATERIALS AND METHODS: This study is part of a prospective, population-based longitudinal study, where women with PCOS diagnosis by age 46 (n = 280) were compared with asymptomatic women (CTRLs, n = 1573). Weight and height data from birth to age 13 years, at age at menarche, and at ages 31 and 46 years were analyzed RESULTS: Women with PCOS had lower birth weight (3357 ± 477 vs. 3 445 ± 505 g, p < 0.001), earlier age at AR (5.2 ± 1.0 vs. 5.6 ± 0.90 years, p < 0.001) and higher BMI from AR onwards compared with controls. Early timing of AR was associated with PCOS diagnosis independently of BMI (OR 1.62, 95% Cl 1.37-1.92). Women with PCOS and early AR had higher BMI at 31 and 46 years when compared to controls with early AR. The age at AR did not associate with T levels at ages 31 or 46 years. CONCLUSIONS: Early AR was associated with PCOS diagnosis and high BMI in adulthood. Adolescent girls with early AR and persisting obesity should be screened for PCOS symptoms, such as persistent irregular cycles and hirsutism.
Date Issued
2019-02-04
Date Acceptance
2018-12-20
Citation
International Journal of Obesity, 2019, 43, pp.1370-1379
ISSN
0307-0565
Publisher
Springer Nature [academic journals on nature.com]
Start Page
1370
End Page
1379
Journal / Book Title
International Journal of Obesity
Volume
43
Copyright Statement
© The Author(s) 2019. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Sponsor
MRC
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30718819
PII: 10.1038/s41366-019-0318-z
Grant Number
G0802782
Subjects
Science & Technology
Life Sciences & Biomedicine
Endocrinology & Metabolism
Nutrition & Dietetics
POLYCYSTIC-OVARY-SYNDROME
ANDROGEN EXCESS
WEIGHT-GAIN
WOMEN
PREVALENCE
OLIGOMENORRHEA
DISORDERS
HIRSUTISM
SYMPTOMS
LIFE
Endocrinology & Metabolism
11 Medical and Health Sciences
13 Education
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2019-02-04